Skip to content
★ Sign in to follow
Osteopore Limited logo

Osteopore Limited Stock: price and insider trades · Australia

ISIN AU0000053324AU·Mcap A$2.8M

Osteopore Limited: what insiders have been doing

This page follows insider dealings at Osteopore Limited as filed with ASX. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 2 insiders.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

There has been no open-market purchase by an insider of Osteopore Limited for at least a year.

With 5 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange.

These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

as of FY 2025

FY ended December 2025 · cache

A$0.00
Analyst consensus
·
Income statement
RevenueA$3.1M
Gross profitA$2.4M78% margin
EBITDA-A$2.9M-95% margin
Net income-A$3.7M-135.8% margin
Valuation
Beta-0.02
Balance sheet & cash
Market capA$2.8M
Total debtA$2.8M
Free Cash Flow-A$2.6M
Profitability & ownership
ROA-57.2%
% insiders18.3%
% institutions4.4%
Last declaration on 10 June 2026
Declarations5 total
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX
  • ●
    Executives
    Executives(filed)
    0ASX

5 of 5 declarations

About Osteopore Limited

Osteopore Limited is an Australian Securities Exchange listed company focused on developing innovative solutions for bone regeneration. It specializes in the research and commercialization of biomedical products.